MPCA
GILD icon

Madison Park Capital Advisors’s Gilead Sciences GILD Stock Holding History

Madison Park Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Buy
5,500
+3,570
+185% +$470K 0.22% 50
2026
Q1 		$269K Hold
1,930
– – 0.21% 50
2025
Q4 		$237K Sell
1,930
-67
-3% -$8.14K 0.19% 58
2025
Q3 		$222K Sell
1,997
-68
-3% -$7.73K 0.18% 56
2025
Q2 		$229K Buy
+2,065
New +$220K 0.19% 54

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Madison Park Capital Advisors's GILD Position: Q2 2026 in Review

Madison Park Capital Advisors increased its Gilead Sciences (GILD) stake by 185% in Q2 2026, buying an estimated $470K and bringing the position to 5,500 shares worth $310K. The position accounts for 0.22% of the portfolio, ranked #50.

Madison Park Capital Advisors first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Madison Park Capital Advisors held 5,500 shares of Gilead Sciences worth $310K as of Q2 2026.
  • Madison Park Capital Advisors bought 3,570 Gilead Sciences shares in Q2 2026, an estimated $470K.
  • Gilead Sciences made up 0.22% of Madison Park Capital Advisors's portfolio in Q2 2026, its #50 holding.
  • Madison Park Capital Advisors first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Madison Park Capital Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.